Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SuAx: Sequential Sunitinib and Axitinib in Metastatic ccRCC
NCT03592199Phase 2Unknown
- Sponsor
- Instituto do Câncer do Estado de São Paulo
- Start
- Dec 2017
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sunitinib, axitinib in clear cell renal cell carcinoma (ccRCC), sponsored by Instituto do Câncer do Estado de São Paulo. Status: unknown.
02
Drugs
sunitinibaxitinib
03
Conditions
clear cell renal cell carcinoma (ccRCC)
Beyond the preview
Go deeper on NCT03592199.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03592199.